Vivek Mittal

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Squamous Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Nature communications

The Journal of cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 15 (1) (2024)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Jun Sun, Lingling Hu, Seoyeon Bok, Alisha R Yallowitz, Michelle Cung, Jason McCormick, Ling J Zheng, Shawon Debnath, Yuzhe Niu, Adrian Y Tan, Sarfaraz Lalani, Kyle W Morse, Daniel Shinn, Anthony Pajak, Mohammed Hammad, Vincentius Jeremy Suhardi, Zan Li, Na Li, Lijun Wang, Weiguo Zou, Vivek Mittal, Mathias P G Bostrom, Ren Xu, Sravisht Iyer, Matthew B Greenblatt
A vertebral skeletal stem cell lineage driving metastasis. Nature (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Albert S Agustinus, Duaa H Al-Rawi, Bhargavi Dameracharla, Ramya Raviram, Bailey S C L Jones, Stephanie Stransky, Lorenzo Scipioni, Jens Luebeck, Melody DiBona, Danguole Norkunaite, Robert M Myers, Mercedes Duran, Seongmin Choi, Jorge S Reis-Filho, Shira Yomtoubian, Andrew McPherson, Eléonore Toufektchan, Kristina Keuper, Paul S Mischel, Vivek Mittal, Sohrab P Shah, John Maciejowski, Zuzana Storchová, Enrico Gratton, Peter Ly, Dan Landau, Mathieu F Bakhoum, Richard P Koche, Simone Sidoli, Vineet Bafna, Yael David, Samuel F Bakhoum
Epigenetic dysregulation from chromosomal transit in micronuclei. Nature (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Hue Tu Quach, Matthew S Skovgard, Jonathan Villena-Vargas, Rebecca Y Bellis, Navin K Chintala, Alfredo Amador-Molina, Yang Bai, Srijita Banerjee, Jasmeen Saini, Yuquan Xiong, William-Ray Vista, Alexander J Byun, Andreas R de Biasi, Masha Zeltsman, Marissa Mayor, Aurore Morello, Vivek Mittal, Daniel R Gomez, Andreas Rimner, David R Jones, Prasad S Adusumilli
Tumor-targeted non-ablative radiation promotes solid tumor CAR T-cell therapy efficacy. Cancer immunology research (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Michael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, Mitchell Martin, Akanksha Verma, Tito A Sandoval, Chang-Suk Chae, Shira Yomtoubian, Yang Hu, Sahil Chopra, Diamile A Tavarez, Paolo Giovanelli, Dingcheng Gao, Timothy E McGraw, Nasser K Altorki, Olivier Elemento, Juan R Cubillos-Ruiz, Vivek Mittal
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Nasser K Altorki, Zachary H Walsh, Johannes C Melms, Jeffery L Port, Benjamin E Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J Sanfilippo, Vivek Mittal, Alain C Borczuk, Sylvia C Formenti, Benjamin Izar, Timothy E McGraw
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications 14 (1) (2023)
Erik Wennerberg, Sumit Mukherjee, Sheila Spada, Clarey Hung, Christopher J Agrusa, Chuang Chen, Amanda Valeta-Magara, Nils-Petter Rudqvist, Samantha J Van Nest, Mohamed K Kamel, Abu Nasar, Navneet Narula, Vivek Mittal, Geoffrey J Markowitz, Xi Kathy Zhou, Prasad S Adusumilli, Alain C Borczuk, Thomas E White, Abdul G Khan, Paul J Balderes, Ivo C Lorenz, Nasser Altorki, Sandra Demaria, Timothy E McGraw, Brendon M Stiles
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science translational medicine 14 (636) (2022)
Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D Foulkes, Diane R Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A Brekken, Lars A Akslen, Randolph S Watnick
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature communications 13 (1) (2022)
Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D Foulkes, Diane R Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A Brekken, Lars A Akslen, Randolph S Watnick
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature communications 13 (1) (2022)
Abdel Razaq Ahmad A Alyasin, Borko Amulic, Monowar Aziz, Betsy J Barnes, Evgeniy B Eruslanov, Zvi G Fridlender, Helen S Goodridge, Zvi Granot, Andrés Hidalgo, Anna Huttenlocher, Mariana J Kaplan, Ilaria Malanchi, Taha Merghoub, Etienne Meylan, Vivek Mittal, Mikaël J Pittet, Andrea Rubio-Ponce, Irina A Udalova, Timo K van den Berg, Denisa D Wagner, Ping Wang, Arturo Zychlinsky, Karin E de Visser, Mikala Egeblad, Paul Kubes
Neutrophil phenotypes and functions in cancer: A consensus statement. The Journal of experimental medicine 219 (6) (2022)
Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D Foulkes, Diane R Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A Brekken, Lars A Akslen, Randolph S Watnick
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature communications 13 (1) (2022)
Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D Foulkes, Diane R Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A Brekken, Lars A Akslen, Randolph S Watnick
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature communications 13 (1) (2022)
Lufei Sui, Suming Wang, Debolina Ganguly, Tyler P El Rayes, Cecilie Askeland, Astrid Børretzen, Danielle Sim, Ole Johan Halvorsen, Gøril Knutsvik, Jarle Arnes, Sura Aziz, Svein Haukaas, William D Foulkes, Diane R Bielenberg, Arturas Ziemys, Vivek Mittal, Rolf A Brekken, Lars A Akslen, Randolph S Watnick
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nature communications 13 (1) (2022)
Rossella Marullo, Monica Castro, Shira Yomtoubian, M Nieves Calvo-Vidal, Maria Victoria Revuelta, Jan Krumsiek, Andrew Cho, Pablo Cresta Morgado, ShaoNing Yang, Vanina A Medina, Berta M Roth, Marcelo Bonomi, Kayvan R Keshari, Vivek Mittal, Alfredo Navigante, Leandro Cerchietti
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases. Science advances 7 (45) (2021)
Yi Ban, Geoffrey J Markowitz, Yue Zou, Divya Ramchandani, Jeffrey Kraynak, Jianting Sheng, Sharrell B Lee, Stephen T C Wong, Nasser K Altorki, Dingcheng Gao, Vivek Mittal
Radiation-activated secretory proteins of Scgb1a1 + club cells increase the efficacy of immune checkpoint blockade in lung cancer. Nature cancer 2 (9) (2021)
Divya Ramchandani, Mirela Berisa, Diamile A Tavarez, Zhuoning Li, Matthew M Miele, Yang Bai, Sharrell B Lee, Yi Ban, Noah Dephoure, Ronald C Hendrickson, Suzanne M Cloonan, Dingcheng Gao, Justin R Cross, Linda T Vahdat, Vivek Mittal
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nature communications 12 (1) (2021)
Eva J Ge, Ashley I Bush, Angela Casini, Paul A Cobine, Justin R Cross, Gina M DeNicola, Q Ping Dou, Katherine J Franz, Vishal M Gohil, Sanjeev Gupta, Stephen G Kaler, Svetlana Lutsenko, Vivek Mittal, Michael J Petris, Roman S Polishchuk, Martina Ralle, Michael L Schilsky, Nicholas K Tonks, Linda T Vahdat, Linda Van Aelst, Dan Xi, Peng Yuan, Donita C Brady, Christopher J Chang
Connecting copper and cancer: from transition metal signalling to metalloplasia. Nature reviews. Cancer (2021)
Muhan Chen, Dawid G Nowak, Navneet Narula, Brian D Robinson, Kaitlin Watrud, Alexandra J Ambrico, Tali M Herzka, Martha E Zeeman, Matthias Minderer, Wu Zheng, Saya H Ebbesen, Kendra S Plafker, Carlos Stahlhut, Victoria M Y Wang, Lorna Wills, Abu Nasar, Mireia Castillo-Martin, Carlos Cordon-Cardo, John E Wilkinson, Scott Powers, Raffaella Sordella, Nasser K Altorki, Vivek Mittal, Brendon M Stiles, Scott M Plafker, Lloyd C Trotman
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. The Journal of cell biology 216 (3) (2017)